questions about the safety of Multaq (dronedarone) for atrial fibrillation

Please see the July 2011 FDA warning concerning Multaq and an increased risk of serious adverse events

New concerns raise questions about the safety of Multaq (dronedarone) for atrial fibrillation.

This is especially important since the most recent guidelines recommend Multaq before amiodarone in many cases for A fib.

Multaq is less effective than amiodarone...but it SEEMED safer.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote